Israeli medical cannabis company planning early Malta expansion

Published by
The Malta Business Weekly

An Israeli medical cannabis company, Panaxia, has announced a €6 million investment and is set to deepen its connection with Malta as it plans a further expansion to its local production plant – thus increasing its capital investment.

This was announced during a visit to Panaxia’s Ħal Far plant by Minister for the Environment, Energy and Enterprise Miriam Dalli. The company has just obtained the GMP license for the facility in Malta upon the completion of the first phase of investment and will export their first products to Germany in the coming weeks.

Aart from the Malta plant, Panaxia operates from locations within the United States, Canada and South Africa, while also being in the process to register products in Portugal, Greece, Poland and Brazil amongst others. Its range of pharmaceutical products, over 60 in all, are mainly based on cannabis plant extracts and treat a variety of ailments including nausea, anxiety and depression.

Panaxia aims to enrich the Maltese production portfolio with products aimed for both Europe and Latin American markets. The Malta facility will therefore diversify into an array of products ranging from production of tablets, oil and extract production, as well as clinical trials, stability experiments and research and development.

During the visit, Minister Dalli, whilst thanking Panaxia for their trust in Malta’s jurisdiction, described Panaxia as an early success story for one of Malta’s newest economic niches.

“Malta Enterprise has been in discussions with Panaxia since the early days after the enacted legislation in 2018. Today, Panaxia is only marking the start of its actual production, but it is already planning an expansion in its facilities. This is another milestone reached for our medical cannabis industry – an industry which further enriches our wider pharmaceutical sector. Malta is the ideal location for such operations, whereby specialised products are developed for the global healthcare supply chain,” Minister Dalli said.

Dadi Segal, CEO of Panaxia, expressed his appreciation towards the company’s local team and thanked Malta Enterprise for its support; “I am impressed with the role of Malta Enterprise in their support to our Malta team at Panaxia on various levels, not just the financial assistance but also the constant communication and facilitation. We had to build this facility from scratch and the process was long but soothed through Malta Enterprise’s constant guidance.”

The Malta Business Weekly

In 1994, the Malta Business Weekly became the first newspaper fully dedicated to business. Today this newspaper is a leader in business and financial news. Together with the launch of the MBW newspaper, the company started organising various business breakfasts to discuss various current issues that were targeting the business community in Malta.

Recent Posts

MedSky Airways announces inaugural of its Benghazi-Malta flight

MedSky Airways is proud to announce the inaugural flight of its new service between Benghazi…

20 hours ago

Passenger traffic through Malta International Airport grows by 15% in 2024

8.96 million passengers welcomed, with Company eyeing further growth in 2025Winter months grew by 21%;…

20 hours ago

Over 20,000 enforcement inspections conducted by OHSA and BCA inspectors in 2024

The Occupational Health and Safety Authority (OHSA) and the Building and Construction Authority (BCA) have…

23 hours ago

Number of tourist arrivals up by 19.5% in first 11 months of 2024 – NSO

Inbound tourists for the first eleven months of 2024 amounted to 3,371,249, an increase of…

23 hours ago

Has inflation targeting served the Eurosystem well?

Alexander Demarco is the Acting Governor at the Central Bank of Malta In last week’s…

1 day ago

The UN’s world economic situation and prospects 2025

The World Economic Situation and Prospects 2025 report was recently published by the United Nations…

1 day ago